News | Radiation Therapy | February 07, 2017

First U.K. Hospital Applies Dolphin Quality Assurance System for Radiation Therapy

Northern Ireland cancer center will now be able to perform fully independent, measurement-based quality assurance for IMRT and VMAT treatments

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.

February 7, 2017 — IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready Patient QA and Monitoring solution in the United Kingdom.

With the use of Dolphin attached to the hospital’s TrueBeam treatment machine, the team at the North West Cancer Centre in Londonderry, Northern Ireland, set a new standard for high quality cancer therapy and a more efficient patient quality assurance (QA) process.

“With Dolphin we can perform fully independent, measurement-based quality assurance of our most advanced IMRT [intensity modulated radiation therapy] and VMAT [volumetric arc therapy] treatments quickly and confidently.” said Andrew Reilly, M.D., head of radiotherapy physics at the North West Cancer Centre, Londonderry. He continued, “Being so straightforward to use, it allows us to plan to the capabilities of the treatment machines, rather than limiting what we do because legacy verification processes cannot keep up. This ensures our clinicians can offer the best possible care to their patients.”

Wendy Hyland, M.D., radiotherapy physicist added, “The measurement process is so easy I can spend more time thinking about what the results mean rather than worrying about the measurements themselves.”

Dolphin is a complete solution that offers a higher capability to detect and verify possible treatment dose discrepancies compared to conventional QA solutions, according to IBA, thus contributing to a more efficient and safer radiation therapy. This improvement is based on Dolphin’s significantly higher treatment dose measurement resolution.

Highly complex IMRT and rotational treatment plans are delivered and measured with the Dolphin transmission detector prior to each patient treatment. A sophisticated TPS-Class software allows verification of dose deviations in 3-D patient anatomy between the plan and actual delivered dose measured with Dolphin.

The hospital’s patient QA workflow efficiency is increased with Dolphin’s “plug and play” wireless setup and its automatic verification software displaying instant QA results.

The Dolphin solution including the detector and the software is online-ready and currently used for pre-treatment QA. The system will be capable of measuring the actual patient treatment dose in online mode, fraction by fraction. The online capability is currently pending release.

For more information: www.iba-dosimetry.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...